PRTN3 and rheumatoid arthritis: Since RF- and ACPA-negative RA typically showed less bony erosion and structural damage, and exhibited a modest disease course [38], we speculate these patients might respond better to TNF-α inhibitors with less discontinuation due to inefficacy, leading to better drug retention rates.